Please use this identifier to cite or link to this item: https://doi.org/10.1155/2015/126793
DC FieldValue
dc.titlePerspectives of Cosmesis following Breast Conservation for Multifocal and Multicentric Breast Cancers
dc.contributor.authorTan, M.P
dc.contributor.authorSitoh, N.Y
dc.contributor.authorSitoh, Y.-Y
dc.date.accessioned2020-09-14T08:19:24Z
dc.date.available2020-09-14T08:19:24Z
dc.date.issued2015
dc.identifier.citationTan, M.P, Sitoh, N.Y, Sitoh, Y.-Y (2015). Perspectives of Cosmesis following Breast Conservation for Multifocal and Multicentric Breast Cancers. International Journal of Breast Cancer 2015 : 126793. ScholarBank@NUS Repository. https://doi.org/10.1155/2015/126793
dc.identifier.issn2090-3170
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/176159
dc.description.abstractBackground. Contemporary data suggest that breast conservation treatment (BCT) for multifocal and multicentric breast cancer (MFMCBC) may be appropriate with noninferior local control rates. However, there is a paucity of data to evaluate patient's satisfaction with cosmetic outcomes after BCT for MFMCBC. This study was performed to bridge this information gap. Methods. All patients treated at the authors' healthcare facility were included in the study. Patients with MFMCBC who were assessed to be eligible for BCT underwent tumour resection using standard surgical techniques with direct parenchymal closure through a single incision. After at least three years of follow-up, they were invited to participate in a survey regarding their cosmetic outcomes. Results. Of a total of 160 patients, 40 had MFMCBC, of whom 34 (85%) underwent successful BCT. Five-year cancer-specific survival and disease-free survival were 95.7%. Twenty of the 34 patients responded to the survey. No patient rated her cosmetic outcome as "poor." Analysis indicated low agreement between patients' self-assessment and clinician-directed evaluation of aesthetic results. Conclusion. BCT for MFMCBC is feasible with acceptable survival and cosmetic outcomes. However, there appears to be a disparity between patient and clinician-directed evaluation of cosmetic results which warrant further research. © 2015 Mona P. Tan et al.
dc.sourceUnpaywall 20200831
dc.subjectantineoplastic agent
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectbreast cancer
dc.subjectcancer adjuvant therapy
dc.subjectcancer chemotherapy
dc.subjectcancer hormone therapy
dc.subjectcancer patient
dc.subjectcancer radiotherapy
dc.subjectcancer specific survival
dc.subjectcancer surgery
dc.subjectclinical article
dc.subjectdisease free survival
dc.subjectesthetic surgery
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjectmultimodality cancer therapy
dc.subjectmultiple cancer
dc.subjectoutcome assessment
dc.subjectpartial mastectomy
dc.subjectpatient satisfaction
dc.subjectpriority journal
dc.subjectsurgical technique
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1155/2015/126793
dc.description.sourcetitleInternational Journal of Breast Cancer
dc.description.volume2015
dc.description.page126793
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1155_2015_126793.pdf3.37 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.